MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite ...
The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.
Through Friday, with the latest quarterly results in from more than three-fifths of the S&P 500, 77% have turned in earnings per share higher than analysts expected, according to FactSet.
It's past the peak of earnings season and results have been largely favorable, with 60% of companies so far beating sales ...
Learn about the potential gains of iShares MSCI Global Metals & Mining Producers ETF in base metals despite short-term trends ...
CPI data, Powell’s remarks, and retail sales will shape market sentiment. Earnings from McDonald’s, Roku, and Coinbase add ...